Business Wire

Duco Focuses on Cutting Investigation Overhead with New Real-Time Automation Module

11.7.2017 09:01 | Business Wire

Jaa

Duco, the global provider of self-service data normalization and reconciliation services, today announces the official launch of Duco Cube Insight, a real-time analysis module for reconciliations that enables firms to cut down root cause investigation time around operational issues. The module was made available to Duco clients in the first quarter of 2017. Since then there has been significant uptake across both buy-side and sell-side firms.

Richard Hunter, Deputy Head of Single Investment Manager Operations at Man Group, said: “We have been working closely with Duco on the design of Duco Cube Insight, based on our knowledge of operational best practice. Complexity in post-trade processes, especially in derivatives and contracts for difference (CFDs), means that investigation of issues between fund administrators, custodians and brokers can be labour intensive. Insight does a lot of the legwork that would have previously been done manually, saving us time on a daily basis and reducing operational risk.”

By using Insight, firms can connect cash, trading and regulatory control processes around multiple counterparties and internal systems. This reduces time spent finding the “needle in the haystack” when discrepancies occur. Operations teams can quickly target and fix issues across all processes, without needing to carry out detailed investigation of each individual reconciliation.

Christian Nentwich, CEO of Duco, said: “Our goal is to make managing data easy. We have already cracked self-service reconciliation, empowering business users to compare arbitrary data sets at scale and saving our clients 5000 man hours per day. We are now moving beyond that by generating operational efficiency based on fully exploiting this data and further reducing the daily task load. Duco Cube Insight gives operations departments another weapon in their arsenal as they build tomorrow’s lean, agile processes.”

Jeffrey Gangl, Chief Revenue Officer of Duco, added: “Our latest innovation has brought a new and unique perspective to the market, leading to rapid adoption across our client base. With Insight, our clients can more effectively scale their businesses with greater control. It is also a key ingredient for our prime services and fund administration community to provide cutting edge technology to their own clients. We look forward to working with our strategic clients to add further innovation in the data preparation and analytics space.”

About Duco

Duco’s mission is to make managing data easy. As the market leader in self-service reconciliation, Duco empowers users to deal with complex data in a fraction of the time required by traditional systems. New clients are live in 24 hours, with reconciliations in production in 7 days and value in 30 days. Customers include international banks, brokers, exchanges, hedge funds, asset managers, fund administrators, payments companies and corporates. Headquartered in London, with offices in New York and Luxembourg, Duco serves clients throughout Europe, the United States, Africa, Asia, the Middle East and Australia.

Contact information

Duco
Chris Peacock
+44(0)2031119294
press@du.co

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme tältä julkaisijalta, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Major Terrorist Plot Foiled in Saudi Arabia, Ministry of Interior Announces21.7.2017 21:33Tiedote

The following is a statement from Saudi Arabia’s Ministry of Culture and Information: This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170721005575/en/ Weapons and other items found in the possession of the three terrorists are an indication of the ugliness and severity of the acts of terrorism they were planning to carry out, victimizing innocent lives and private and public property. (Photo: ME NewsWire) The Saudi Ministry of Interior has announced that a major terrorist attack was prevented by security services in the city of Saihat in the Qatif governorate. On the evening of Friday, July 14th, security services intercepted a stolen Toyota Corolla vehicle in a busy, built-up district of the city. As the stolen vehicle was surrounded by security services, three men in the ca

Janssen Receives Positive CHMP Opinion for SYMTUZA™ The First Darunavir-Based Single-Tablet Regimen for the Treatment of HIV21.7.2017 15:09Tiedote

Janssen-Cilag International NV (Janssen) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a Positive Opinion recommending marketing authorisation for SYMTUZA™ (darunavir/cobicistat/emtricitabine/tenofovir alafenamide [D/C/F/TAF]), a once-daily darunavir-based single tablet regimen (STR). If approved, it will be the only darunavir-based STR indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and adolescents aged 12 years and older with body weight of at least 40 kg, with genotypic testing guiding use. This STR combines the proven efficacy and durability of darunavir with the improved renal laboratory and bone mineral density profile of F/TAF as compared to F/TDF (tenofovir disoproxil fumarate), and will be the only treatment that could deliver the adherence advantag

Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (Telotristat Ethyl), for the Treatment of Carcinoid Syndrome Diarrhea in Patients Inadequately Controlled by Somatostatin Analogue Therapy21.7.2017 14:26Tiedote

Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA), has adopted a positive opinion recommending the approval of Xermelo® (telotristat ethyl) 250 mg three times a day (tid) for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analogue (SSA) therapy in adults inadequately controlled by SSA therapy. The CHMP positive opinion will now be reviewed by the European Commission (EC), which has the authority to approve medicines for use in the 28 countries of the European Union, as well as Norway, Liechtenstein and Iceland. David Meek, Chief Executive Officer of Ipsen, said: “The positive CHMP opinion for Xermelo ® is an important milestone towards providing innovative s

NRI Secure Launches Japan's First "Blockchain Assessment" Service21.7.2017 10:00Tiedote

NRI SecureTechnologies, Ltd. (President: Jun Odashima; hereinafter NRI Secure), a leading provider of information security solutions in Japan, has begun providing Japan’s first-ever*1 “Blockchain Assessment,” a security Assessment service designed for systems and services which use blockchain technology*2. This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170721005012/en/ Overview of the "Blockchain Assessment" Service (Graphic: Business Wire) As the blockchain technology has become more widespread, the presence of security-related vulnerabilities has also become increasingly apparent. In particular, with regard to smart contracts, *3 one of a constituent element of services using the blockchain, a cyberattack carried out on any vulnerable programs could lead to major threats or eve

Business Figures for the First Half of 2017: Sartorius Continues to Grow21.7.2017 08:00Tiedote

Sartorius (FWB:SRT), a leading international laboratory and pharmaceutical equipment supplier, continues on the growth track. In the first half of 2017, solid organic business development and two acquisitions led to a significant increase in sales revenue and earnings1. "Sartorius has continued its dynamic, profitable development," said CEO and Executive Board Chairman Dr. Joachim Kreuzburg in commenting on the company's first-half performance. "Both divisions achieved solid organic growth in an environment that was especially challenging in North America, and have made quick progress in integrating the businesses most recently acquired. In the Lab Products & Services Division, the bioanalytics unit newly created by our acquisitions has already contributed significant revenues and earnings. We see further considerable growth potential ahead for this business just as for the

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme